Dr. Päivi Tammela

Päivi Tammela received her Ph.D. in Pharmacy in 2004 (University of Helsinki, Finland). Dr. Tammela has served as University Lecturer in Pharmaceutical Biology (2005-2007) at the University of Helsinki; and obtained Adjunct Professorship in Pharmaceutical Biology in 2005. Since 2008, she has served as University Researcher and Group Leader at the Centre for Drug Research (CDR), Division of Pharmaceutical Biosciences, where she leads the Bioactivity Screening Group. Currently, she holds the Academy of Finland Research Fellow position (2014-2019). Dr. Tammela has authored more than 40 peer-reviewed articles and 7 patents.

In the INTEGRATE-ETN, Dr. Tammela is the main supervisor for ESR3 and acts as the Director of Training. The research project of ESR3 focuses on employing novel tools in antibacterial drug discovery (WP3).



This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska Curie grant agreement No  642620
European Union